A Life Sciences Matching Platform
Organize, translate, share,
and discuss your research
— all in one platform
Publish your research outcomes in a format global investors and pharmaceutical companies can evaluate.
Create opportunities for collaboration and partnering through direct engagement.
Free to use during our early access period.
Free access is available until September 30, 2026. You will not be charged if you cancel before then.
Do any of these sound familiar?
You can’t get your research materials
ready in English
You’re unsure what you can disclose
considering patents and IP
You don’t have
a safe place to talk
with overseas VCs and pharma
How iDCP helps
Turn your research into a clear story (in English)
We start by organizing what matters: what’s new, how far it has progressed, and what you need next.
Then we shape it into an English overview that global investors and pharmaceutical companies can quickly understand.
Share step by step—with the right level of confidentiality
Execute an NDA within the platform to securely share confidential information.
You can open access gradually—overview first, additional data later—so you don’t have to “share everything at once.”
Get discovered by global investors and pharma
Your research becomes searchable and recommended to investors and pharmaceutical companies worldwide.
This opens the door to collaboration and partnering opportunities.
How It Works
Register your research
Start by sharing a document or website URL.
AI extracts the key points and drafts an English overview—bringing it closer to the format investors and pharma expect.
Get contacted by investors and pharma
Your research becomes searchable and recommended.
Interested investors and pharmaceutical companies can reach out to you directly.
Chat, align, and set up meetings
Chat directly on the platform to align on requirements and coordinate meetings.
When needed, you can execute an NDA and proceed at a comfortable pace.
Getting Started
Sign up
You can sign up by clicking the "Sign Up" button on this page or via the link here. Follow the on-screen instructions to enter your organization and research information.
Review
After submitting your information, we’ll conduct a brief review. This may take a few business days.
Enter Payment Information
By entering your payment information, you will gain access to all features.
Currently available for free during the early access period.
The free period is available until September 30, 2026. If you cancel before this date, you can use the service at no cost.
Start Using iDCP
Register your research and set your disclosure level. You’ll be ready to receive messages from investors and pharmaceutical companies.
FAQ
We've answered some frequently asked questions below.
If you have any further questions, please feel free to contact us.
iDCP is primarily designed for biotech startups and academic institutions. Any organization that wants to organize and share research data, papers, or slides in a format that global VCs and pharmaceutical companies can evaluate is welcome, regardless of size or industry.
We use the latest AI models, specialized in life sciences, to perform structuring and translation. Users can review, add, and revise the content themselves, ensuring accuracy for highly specialized research. Final adjustments are made by users to reflect their expertise.
After uploading your organization's URL and input data files, AI structuring and translation are completed within minutes to tens of minutes. You can then review, add, and edit the content as needed.
Yes. We activate iDCP by leveraging the science-focused community and expertise cultivated through iPark. Based on research content and objectives, we help create meaningful connections and collaboration opportunities.
All data is encrypted and managed under strict access controls. You can freely designate information as Confidential. Confidential information will not be disclosed to other users unless an individual NDA is executed on iDCP.